BETA: Please send your feedback!

Neurocrine Biosciences

NAS:NBIX

Biotechnology

MID cap
(—)
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale on January, 1992 and is headquartered in San Diego, CA.
website

Headquarters

12780 El Camino Real
San Diego, CA 92130

Executives

Name Title Gender
Errol B. de Souza, PhD Founder Male
Kevin Charles Gorman, PhD, MBA Chief Executive Officer & Director Male
Christopher Flint O'Brien, MD Chief Medical Officer Male
Darin M. Lippoldt Chief Legal Officer Male
William H. Rastetter, PhD Chairman Male
Paul W. Hawran, CPA Founder Male
Wylie W. Vale, PhD Founder Male
Dimitri E. Grigoriadis, PhD Chief Research Officer Male
Bill Wilson Vice President-Information Technology & Operations Male
Malcolm Lloyd-Smith Chief Regulatory Officer Male
Jane Sorensen Head-Investor Relations Female
David-Alexandre C. Gros, MD, MBA President, Chief Operating & Financial Officer Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

Neurocrine Biosciences - Competitors and Related Companies

How Neurocrine Biosciences stacks up to its peers in the Biotechnology industry or with competing business segments.

Neurocrine Biosciences

NAS:NBIX

Biotechnology

MID cap
(—)
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…